Bone mineral density is associated with site-specific atherosclerosis in patients with severe peripheral artery disease

Calcified Tissue International

Volumn 93, Issue 1, 2013, Pages 55-61

  Fehérvári, Mátyás ^a   Sarkadi, Hunor ^a   Krepuska, Miklós ^a   Sótonyi, Péter ^a   Acsády, György ^a   Entz, László ^a   Lakatos, Péter ^a   Szeberin, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Atherosclerosis; BMD; Bollinger score; Dyslipidemia; Osteoporosis; Vitamin D3

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; COLECALCIFEROL; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; AGED; ARTERIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BONE DENSITY; BONE TURNOVER; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; HUMAN; ILIAC ARTERY OBSTRUCTION; LEG ISCHEMIA; LIMB BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; AGED; ATHEROSCLEROSIS; BONE DENSITY; CHOLECALCIFEROL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PERIPHERAL ARTERIAL DISEASE;

EID: 84879800319     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-013-9727-5     Document Type: Article

References (29)

1. Hyder JA, Allison MA, Criqui MH, Wright CM (2007) Association between systemic calcified atherosclerosis and bone density. Calcif Tissue Int 80:301-306
2. Mangiafico RA, Russo E, Riccobene S, Pennisi P, Mangiafico M, D'Amico F, Fiore CE (2006) Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women. J Bone Miner Metab 24:125-131
3. von Muhlen D, Allison M, Jassal SK, Barrett-Connor E (2009) Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study. Osteoporos Int 20:2071-2078
4. von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273-278
5. Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazieres B (1994) Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13:611-614
6. Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, Vaccarino V, Zhang Y, Kiel DP (2004) Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone 34:557-561
7. Jensky NE, Hyder JA, Allison MA, Wong N, Aboyans V, Blumenthal RS, Schreiner P, Carr JJ, Wassel CL, Ix JH, Criqui MH (2011) The association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis. J Bone Miner Res 26:2702-2709
8. Lupattelli G, Scarponi AM, Vaudo G, Siepi D, Roscini AR, Gemelli F, Pirro M, Latini RA, Sinzinger H, Marchesi S, Mannarino E (2004) Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism 53:744-748
9. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49:211-217
10. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680-687
11. Stojanovic OI, Lazovic M, Vuceljic M (2011) Association between atherosclerosis and osteoporosis, the role of vitamin D. Arch Med Sci 7:179-188
12. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V (2007) Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 158:1-235
13. Anagnostis P, Athyros VG, Adamidou F, Florentin M, Karagiannis A (2010) Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk? Curr Vasc Pharmacol 8:720-730
14. Biver E, Chopin F, Coiffier G, Brentano TF, Bouvard B, Garnero P, Cortet B (2012) Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. Joint Bone Spine 79:20-25
15. Chailurkit L, Kruavit A, Rajatanavin R, Ongphiphadhanakul B (2011) The relationship of fetuin-A and lactoferrin with bone mass in elderly women. Osteoporos Int 22:2159-2164
16. Mori K, Emoto M, Inaba M (2012) Fetuin-A and the cardiovascular system. Adv Clin Chem 56:175-195
17. Szeberin Z, Fehervari M, Krepuska M, Apor A, Rimely E, Sarkadi H, Szeplaki G, Prohaszka Z, Kalabay L, Acsady G (2011) Serum fetuin-A levels inversely correlate with the severity of arterial calcification in patients with chronic lower extremity atherosclerosis without renal disease. Int Angiol 30:474-475
18. Ford ML, Tomlinson LA, Smith ER, Rajkumar C, Holt SG (2010) Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol Dial Transplant 25:1853-1858
19. Shioi A, Nishizawa Y (2009) Vascular calcification in chronic kidney disease: pathogenesis and clinical implications. J Ren Nutr 19:78-81
20. Fodor D, Bondor C, Albu A, Muntean L, Simon SP, Poanta L, Craciun A (2011) Relation between intima-media thickness and bone mineral density in postmenopausal women: a cross-sectional study. Sao Paulo Med J 129:139-145
21. Choi SH, An JH, Lim S, Koo BK, Park SE, Chang HJ, Choi SI, Park YJ, Park KS, Jang HC, Shin CS (2009) Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre- and postmenopausal women. Clin Endocrinol (Oxf) 71:644-651
22. Beer S, Saely CH, Hoefle G, Rein P, Vonbank A, Breuss J, Gaensbacher B, Muendlein A, Drexel H (2010) Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men. Osteoporos Int 21:1695-1701
23. Bollinger A, Breddin K, Hess H, Heystraten FM, Kollath J, Konttila A, Pouliadis G, Marshall M, Mey T, Mietaschk A, Roth FJ, Schoop W (1981) Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 38:339-346
24. Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50-57
25. Holick MF (2000) Calcium and vitamin D. Diagnostics and therapeutics. Clin Lab Med 20:569-590
26. Maes C, Carmeliet G, Schipani E (2012) Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol 8:358-366
27. Hung SP, Ho JH, Shih YR, Lo T, Lee OK (2012) Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J Orthop Res 30:260-266
28. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520-528
29. Persy V, D'Haese P (2009) Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15:405-416